Clinical Trial Update: Prothrombin Complex Concentrate for Anticoagulant Reversal [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Prothrombin Complex Concentrate for reversing anticoagulation in patients with acquired coagulation factor deficiency has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Coagulation Factor Deficiency

Drugs mentioned

• Prothrombin Complex Concentrate (prothrombin complex concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Acquired Coagulation Factor Deficiency | Phase 3 | Status: COMPLETED